Top 5 Small-cap Biotech Stocks of 2025
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in response to breakthrough innovations...
The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is still trading at three-year highs, despite current market volatility, in response to breakthrough innovations...
StrategX Elements Corp. (CSE: STGX) (‘StrategX’ or the ‘Company’) announces that Gary Wong has stepped down from his role as...
Stock Market News: UK Forecast and Technical Analysis Today, the UK stock market saw the FTSE 250 increase by 195 points (0.9%)...
Stock Market News: UK Forecast and Technical Analysis Today, the UK stock market saw the FTSE 250 increase by 195 points (0.9%)...
Thank You! I’ve been writing at StockCharts.com for nearly 20 years now and many of you have supported my company,...
You may not know it, but all of the Magnificent Seven stocks are in bear markets. Given they are such...
Brazil-focused explorer Alvo Minerals (ASX:ALV,OTC Pink:ALVMF) has signed a non-binding letter of intent with Pan American Silver (TSX:PAAS,NYSE:PAAS) to acquire...
Stock Market News: UK Forecast and Technical Analysis Today, the UK stock market saw the FTSE 250 increase by 195 points (0.9%)...
Stock Market News: UK Forecast and Technical Analysis Today, the UK stock market saw the FTSE 250 increase by 195 points (0.9%)...
Copyright © 2025 InvestDailyPro. All Rights Reserved.
Disclaimer: InvestDailyPro.com, its managers, its employees, and assigns (collectively InvestDailyPro ) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.